In peritoneal dialysis, a sterile electrolyte solution totoneal dialysis solutions.
. Composition of constituent amino acids in nutritional point of view [10] . One such amino acid is amino acid-based (Nutrineal) solution tyrosine, which is considered essential in patients with Molecular Concentration renal failure due to reduced generation from phenylala-Amino acids weight mmol/L nine [11] . However, dipeptides of tyrosine, such as ala- [12] . Glycyl-tyrosine has been added to amino acid solu- into their constituent amino acids [13] . Similarly, after parenteral administration, dipeptides are rapidly metab-Glycine 75.1 6.79 olized and free amino acids are produced [10, 12] . the peritoneal cavity. They may even be hydrolyzed into the constituent amino acids in the peritoneal cavity, thus generating additional osmotically-active molecules, which might further enhance ultrafiltration. Tyrosine-containing The three solutions had the following electrolyte composition: sodium, 132 mmol/L; calcium, 1.25 mmol/L; dipeptides may also be of benefit, since they may be present in the dialysis fluid at higher concentrations than are magnesium, 0.25 mmol/L; lactate, 40 mmol/L; and chloride, 105 mmol/L. possible with free tyrosine.
In the present study, in a rat model we investigated The Dip 8 solution contained half as many moles of dipeptides per liter as the number of moles of free amino the diffusive and convective transport properties of the peritoneum, using a dialysis solution containing an equi-acids in the amino acid-based solution (that is, the osmolality of the amino acid-based solution was approxi-molar mixture of 5 dipeptides at two concentrations, and compared the results with those obtained from a solution mately twice as high). Both the amino acid and the Dip 8 solutions had similar total amino acid contents. The containing free amino acids. We also determined to what extent the dipeptides were hydrolyzed to their constit-Dip 16 solution had similar total molar concentration as the amino acid-based solution (that is, the osmolality was uent free amino acids in the peritoneal cavity, the rate of disappearance of dipeptides and amino acids from the approximately the same) but the amino acid content was twice as high. peritoneal cavity, and the rate of appearance of amino acids in plasma.
Seven of the amino acids in the dipeptide solutions were essential amino acids, that is, leucine, histidine, lysine, phenylalanine, threonine, valine and tyrosine (tyro-METHODS sine is an indispensable amino acid in uremia), which Solutions may be of potential nutritional benefit in future solutions. Market availability and prices were considered when The following solutions were used: (1) an amino acid solution (Nutrineal, AA solution) containing 15 amino selecting the dipeptides to be used. By studying two dipeptide solutions, one hypo-osmolal with the same amino acids in varying proportions and with a total amino acid concentration of 86 mmol/L (its composition is given in acid content as in the amino acid solution and one isoosmolal with double the amino acid content, we could Table 1 ); (2) a weak (Dip 8) solution containing the five dipeptides, glycyl-histidine (Gly-His), alanyl-tyrosine (Ala-analyze the properties of dipeptides as osmotic agents and as providers of amino acids. Tyr), threonyl-leucine (Thr-Leu), seryl-phenylalanine (Ser-Phe) and valyl-lysine (Val-Lys) in equimolar con-Animals centrations (8.4 mmol/L), with a total concentration of dipeptides of 42 mmol/L [alanine-tyrosine was a kind Twenty-four male Sprague-Dawley rats with an average body weight of 300 g were divided into three groups gift from Professor Peter Fü rst (Hohenheim University, Stuttgart, Germany)and all other dipeptides were pur-(with 8 rats in each group). Each rat was anesthetized with a single intraperitoneal injection of 50 mg/kg pure chased from Sigma (St. Louis, MO, USA)]; (3) a strong (Dip 16) solution containing the same five dipeptides in pentobarbital sodium (Pharmacia, Uppsala, Sweden). The fur over the abdominal wall was closely shaved. The double the amounts (16.8 mmol/L) with a total concentration of 84 mmol/L dipeptides.
animal was laid in a supine position and was kept at 37ЊC with a heating pad (CMA/Microdialysis, Stock-Chromatograms were integrated in a computerized data system (Chromatography Data System AB, Stockholm). holm, Sweden). Isotonic saline, 1 mL/hour, was injected subcutaneously to prevent hypovolemia. A multiholed Calculations silastic catheter (0.8 mm internal diameter; Venoflon, Helsingborg, Sweden) was inserted percutaneously in Intraperitoneal dialysate volume (V D ) was estimated the left lower quadrant of the abdomen for dialysis fluid from the dilution of RISA with corrections made for the infusion and sampling. The experiment was started by elimination of RISA from the peritoneal cavity and the giving an intraperitoneal injection of 25 mL of 1.1% sample volume [15] [16] [17] [18] . Note that the intraperitoneal volamino acid dialysis solution (Nutrineal, AA solution) ume at the end of the dwell was directly measured. The or the weak (Dip 8) or strong (Dip 16) dipeptide solution, RISA elimination coefficient (K E ) was calculated using containing 18.5 KBq 131 I-human serum albumin (RISA), a formula reported previously [15] [16] [17] [18] . Since only a very Isopharma AS, Kjeller, Norway) as a peritoneal volume small amount of free iodine was found in the RISA solumarker. The solutions were prewarmed to 37ЊC before tion [19] , we did not take the free iodine into account in injection.
the K E calculation. The actual calculations of K E and time A priming dose of human serum albumin (final concourse of V D were performed using the computer procentration 0.2 g/L) was added to the solutions to minigram PERTRAN (Baxter Novum, Karolinska Institutet, mize the adhesion of tagged albumin to the surface of the Stockholm, Sweden), available at internet address: http:// catheter. After infusion, the dialysis solution remained in www.ibib.waw.pl/~peritome. The peritoneal fluid absorpthe peritoneal cavity for four hours. Dialysate samples tion rate (Q A , mL/min) was estimated as the coefficient (0.35 mL) were taken at 0, 3, 15, 30, 60, 90, 120, 180 and of RISA elimination from the peritoneal cavity, K E . The 240 minutes postinfusion. Prior to each sampling, 1 mL transcapillary ultrafiltration rate (Q U ) was calculated as of the dialysate was flushed back and forth five times the net volume change in time plus K E (Appendix II). through the catheter. Blood samples were drawn at 0, The kinetic model developed for dipeptide transport 30, 60, 120 and 240 minutes from the tail artery. After and hydrolysis as well as transport of amino acids is shown 240 minutes, the peritoneal cavity was opened and dialyin Figure 1 and described in Appendix I (Appendices I, sate was collected, using a syringe and preweighed gauze II and III may be viewed in the online version of the jourtissues and the volume was recorded. The experimental nal at: http://dx.doi.org/10.1046/j. 1523-1755.2001 .00499.S). study was approved by the Animal Ethics Committee of The method of estimating kinetic parameters is de-Karolinska Institutet at Huddinge Hospital.
scribed in Appendix II. Dialysate samples (0.1 mL) were analyzed for RISA The amount (mass) of a particular amino acid transactivity on a Gamma Counter (Packard Instrument Comported from dialysate during the dwells with the amino pany, Meriden, CT, USA) for 10 minutes each. The conacid-based solution, between 3 and 120 minutes of the centrations of amino acids and dipeptides in dialysate dwell, was calculated as follows: and plasma were measured with high-pressure liquid chro-
Ϫ V D (120)C DA (120) matography (HPLC; Waters, Milford, MA, USA).
Amino acid and peptide concentrations in dialysate where V D (3) and V D (120) are dialysate volumes at 3 and and plasma were measured with reverse-phase HPLC, 120 minutes, respectively. C DA (3) and C DA (120) are amino essentially as described by Suliman, Anderstam and Bergacid concentrations at 3 and 120 minutes, respectively. strö m for amino acids [14] . Briefly, samples were depro-
The amount of total amino acids in the dialysate in teinized with 5-sulfosalicylic acid, filtered and stored at dwells with dipeptide-based solutions was calculated as Ϫ70ЊC. The determinations of amino acids and dipepthe sum of the amount of dipeptide (mol) and of contides were carried out using fluorometric detection (Ex ϭ stituent free amino acids (mol). This calculation is valid 340 nm and 450 nm). The method was based on autoonly for amino acids contained in dipeptides in fresh mated precolumn derivatization with orthophthalaldedialysis solution. The amount of a particular amino acid hyde/3-mercaptopropionic acid. Mobile phases used were transported from the dialysate in dwells with dipeptidesolvent A [12.5 mmol/L phosphate buffer, pH 6.93, and based solution could therefore be calculated as: tetrahydrofuran 99:1 (vol:vol)] and solvent B [methanol, Ϫ V D (120)[C DD (120) ϩ C DA (120)] system (Waters Associate) consisted of a Waters system where C DD (3) and C DD (120) are dipeptide concentrations controller 600E and two M-45 pumps, an auto-sampler at 3 and 120 minutes, respectively, and C DA (3) and C DA (120) WISP-712B with a cooling system to optimize the temare concentrations of free constituent amino acids at 3 perature at ϩ4ЊC and a Waters 470 fluorescence detector. and 120 minutes of the dwell. The reason for choosing The amino acids and dipeptides were separated on a C 18 column, 4.6 ϫ 150 mm (YMC Co. Ltd, Kyoto, Japan). measurements at 120 minutes instead of 240 minutes,
Fig. 1. Kinetic model of diffusive and convective transport of dipeptides and amino acids.
Nomenclature is: V D , peritoneal volume; C DD and C BA , dialysate and blood dipeptide concentrations, respectively; C DA and C BA are concentrations of amino acids in dialysate and blood plasma, respectively; K H , the hydrolysis rate of dipeptide; K BDD and K BDA , diffusive mass transport rate coefficients of dipeptides and amino acids, respectively; Q A , fluid absorption rate; Q V , ultrafiltration flow rate. This model does not include exchanges between the blood and extravascular compartments.
the end of the study was that in most cases the dialysate more rapid than that with the Dip 16 solution and similar dipeptide concentrations at 240 minutes were very low to that with the Dip 8 solutions. The average volume and could not be measured with acceptable accuracy.
decreases between 90 and 240 minutes of the dwells were The relative changes in the concentration of amino 3.4 mL and 3.5 mL with Dip 8 and Dip 16 dipeptideacids in plasma were calculated as: based solutions, respectively, and 4.8 mL with the amino acid-based solution.
⌬C DA ⌬M A In Figure 3 , the time courses of the concentrations of particular dipeptides and constituent amino acids in the dialysate during dialysis with the dipeptide-based strong
(Dip 16) solution are shown. The time courses of dipeptides and amino acids obtained with Dip 8 showed similar C BA at 60 minutes was chosen, C BA (60), because the maxipatterns (data not given). The dipeptides disappeared mal concentration of amino acids in plasma occurred at approximately exponentially from the dialysate, while about 60 minutes. The results are expressed as mean Ϯ the concentrations of the constituent amino acids in-SD. Comparisons of normalized plasma amino acid concreased, due to their transport between blood and dialycentrations were performed, using ANOVA and Student sate and the cleavage of dipeptides occurring in the perit test for comparison of kinetic parameters. A P value toneal cavity. of less than 0.05 was considered significant.
The kinetic model allowed for a fairly accurate quantitative description of the complex processes of dipeptide RESULTS hydrolysis in the peritoneal cavity, characterized by the hydrolysis rate coefficient (K H ), and dipeptide diffusion Peritoneal volumes (V D ) over time curves, normalized from the peritoneal cavity to plasma, characterized by by V D at 3 minutes [V D (3)] for the three dialysis solutions, the diffusive mass transport coefficient (K BDD ) ( Fig. 1 and are shown in Figure 2 . Dwells with the amino acid-based Appendix I). Since the plasma dipeptide concentrations solution exhibited an earlier maximum V D than with the Dip 16 solution. The subsequent volume decrease was were negligible, the convective dipeptide transport by ultrafiltration was neglected. Convective flow of dipep-from dipeptides in the peritoneal cavity was described as the product of dipeptide hydrolysis rate (K H ) and C DD . tides from the dialysate was expressed as a product of the fluid absorption rate (Q A ) and the dipeptide dialysate
The model also included transport of constituent amino acids between dialysate and plasma by diffusion (mass concentration (C DD ). The generation rate of amino acids transport rate coefficient, K BDA ) and convection from plasma to dialysate, characterized by the sieving coefficients, S A , as well as convective absorption from the For each dipeptide, K BDD (or K* BDD ) was much higher than K H (or K* H ; Tables 3 and 4 ). This means that transport dialysate, in which the sieving coefficient was assumed to be one. The method for estimating a model's parame-of dipeptides out of the peritoneal cavity occurs at a much higher rate than the rate of hydrolysis. Statistically, ters is given in Appendix II. Table 2 shows the average values of diffusive mass K H and K* H as well as K BDD and K* BDD showed no significant differences, and both methods of estimating kinetic pa-transport coefficients (K BDA ) for 10 amino acids that were estimated from eight experiments with the amino acid-rameters for dipeptides seem to be equally accurate.
Since the concentration of dipeptides in blood was negli-based dialysis solution. The K BDA values for different amino acids did not differ substantially (maximum value gible, there was no convective transport of dipeptides from blood to dialysate with ultrafiltration flow and the of 0.334 Ϯ 0.096 mL/min for glycine and a minimum value of 0.242 Ϯ 0.056 mL/min for phenylalanine). How-only convective transport was by fluid absorption from the peritoneal cavity. The fluid absorption rate (Q A ) was ever, increasing molecular weight was accompanied by decreasing values of K BDA (Fig. 4) . estimated by the volume marker elimination rate (K E ).
The average values of Q A were estimated as 0.026 Ϯ 0.008 The diffusive mass transport coefficients for dipeptides (K BDD ), estimated without any assumption concerning mL/min in dwells with the weak (Dip 8) dipeptide-based solution and 0.031 Ϯ 0.005 mL/min in dwells with the amino acid transport, and K* BDD , estimated with K BDA taken from amino acid-based dwell studies (Table 2) , were strong (Dip 16) dipeptide-based solution. The average values of Q A did not differ statistically between the groups. calculated using data from the dwell studies with weak and strong dipeptide-based dialysis solutions (Table 3) .
These values of Q A were much smaller than the values of K BDD (or K* BDD ), reflecting that the convective transport The difference between K BDD and K* BDD and the methods used in estimation of their values are described in Ap-of dipeptides was very small as compared to the transport by diffusion. pendix II. As shown in Table 3 , the diffusive mass transport coefficients for dipeptides, K BDD or K* BDD tended to Table 5 shows the amounts (masses), ⌬M A , and the fractional amounts of amino acids transported from the be higher with the Dip 16 than with the Dip 8 solution.
Another characteristic feature is the dependence of
is the amount of amino acids at 3 minutes of the dwell. These fractional (or K* BDD ) on dipeptide molecular weight. In Figure 4 , the diffusive mass transport coefficients for amino acids amounts were quite similar in the dwells with amino acids and in the dwells with strong and weak dipeptide-(K BDA ) and that for dipeptides (K BDD ) estimated in dwells with weak (Dip 8) solution are presented in reference to based solutions. The time courses of blood concentrations of amino acids the corresponding molecular weights. K BDD estimated in dwells with Dip 8 solution is probably better suited than exhibited an initial rise with maximum values achieved after 30 or 60 minutes, followed by a gradual fall, as shown that of Dip 16 for comparison with K BDA , because the concentrations of amino acids in the amino acid solution in Figure 5 . This pattern was observed in all dwell studies. Histidine, lysine, threonine and serine showed very simi-and of dipeptides in the Dip 8 solution are more similar.
The hydrolysis rate coefficients for the five dipeptides lar plasma amino acids concentration time courses during dwells with the amino acid solution and Dip 8 solution. are presented in Table 4 . It should be noted that the lowest K H values were found for Gly-His with both the We also wished to determine whether the increase in plasma concentrations in relation to the uptake of amino weak and the strong dipeptide-based solutions. K* BDD was calculated with K BDA for amino acids estimated using the amino acid kinetic model and data from amino acid-based dialysis solution (Table 2) . Data are mean Ϯ SD for K BDD and K* BDD . given in the solution in free form or as dipeptides. To study this, the amount (mass) transported from the dialysate (⌬M A ) of histidine, lysine, threonine and serine, DISCUSSION during dwells with the amino acid solution were com-
The reduction in dialysate volume between 90 and pared to the ⌬M A of the same amino acids during dwells 240 minutes with the strong (Dip 16) dipeptide-based with the Dip 8 solution. As shown in Table 5 , the ⌬M A solutions was less rapid than that with the amino acidwas substantially higher for each of these amino acids based solution (Fig. 2) , in spite of the initial osmolality with Dip 8 than with the amino acid-based solution (for being very similar. This seems to be caused by the higher histidine 2.83 times higher, P Ͻ 0.0001; for threonine, molecular weight of the dipeptides and generation of 3.47, P ϭ 0.0001; for serine, 1.84, P ϭ 0.0005; and for constituent amino acids from hydrolysis of dipeptides in lysine, 2.45, P ϭ 0.0019). However, despite these large the peritoneal cavity. differences, the plasma concentrations were very similar
The reason why the weak dipeptide-based solution during the two dwells. results in a similar pattern of peritoneal volume changes Another way to show the relationship between the as the amino acid-based solution (Fig. 2) , despite having plasma concentration of an amino acid and the dose of half the molar concentration, may be that: (1) the diffuthat amino acid transported from the peritoneal cavity sive mass transport coefficient for dipeptides (K BDD ) is is shown in Table 6 . Here the increases in plasma amino smaller than the K BDA for amino acids (Fig. 4) ; and (2) acid concentrations at 60 minutes, ⌬C BA (60), representdipeptides are hydrolyzed in the peritoneal cavity (aling values close to the maximum, are divided by the mass though at lower rate than the rate of their transport from of amino acids transported from the peritoneal cavity dialysate; compare Tables 3 and 4) , which generates free between 3 minutes and 60 minutes (⌬M A ). For all amino amino acids during the dwell. The driving force for changes acids except phenylalanine, the mean ⌬C BA (60)/⌬M A in in peritoneal volume is the difference in concentration the amino acid-based dwell studies was higher than in of an osmotic agent between dialysate and plasma. In the dipeptide-based dwell studies. The difference was the case of dipeptide-based dialysis, this driving force statistically significant for glycine, histidine, leucine and can be approximately expressed as the concentrations (molar) of dipeptides plus concentrations of constituent valine. The higher concentration curve for glycine than for histidine in the dialysate, shown in Figure 3 , is difficult to explain, since hydrolysis of the Gly-His dipeptide should amino acids in the dialysate, minus the concentrations result in the generation of equimolar amounts of the two of corresponding amino acids in blood plasma. As the amino acids and diffusive transport of histidine should diffusive mass transport parameters of the dipeptides and be lower than that of glycine, due to its more than twice amino acids depend on their molecular weights ( Fig. 4) higher molecular weight. One possibility might be that and the hydrolysis rates of the dipeptides are similar histidine removal from the peritoneal fluid is enhanced (except that of Gly-His), we chose Thr-Leu, which has a by its adsorption to peritoneal membrane structures. A representative molecular weight of dipeptide and constithigher concentration of serine than phenylalanine was uent amino acids (Tables 2 and 3) as an example to illusalso observed; in this case the much lower molecular trate the changes in the peritoneal volume driving force.
weight of serine might lead to more rapid removal by The driving force of this single dipeptide in dwells with diffusion than for phenylalanine. Dip 8 solution divided by the value of the driving force
In Figure 4 , the pattern of decreasing K BDA and K BDD at 3 minutes was constantly higher after 60 minutes than with increasing molecular weight is clearly seen. This obthat generated by threonine or leucine in the amino acidservation is in general agreement with thermodynamic based solution. At 180 minutes, it was 0.35 Ϯ 0.10 (mean Ϯ theory, that solutes of higher molecular weight diffuse SD) mmol/L for threonine-leucine, 0.23 Ϯ 0.12 mmol/L more slowly than solutes of lower molecular weight. It is for threonine and 0.20 Ϯ 0.10 mmol/L for leucine.
interesting to note that K BDD and K* BDD from the dwells The average values of K H and K* H as well as the values with the strong (Dip 16) dipeptide-based solution tended of K BDD and K* BDD showed no significant differences. This to be higher than K BDD and K* BDD from the dwells with the analysis confirms that the accuracy of estimating kinetic weak (Dip 8) dipeptide-based solution ( Table 3 ). The parameters for amino acids has little effect on the estimareason for this difference is not clear; however, a similar tion of dipeptide kinetic parameters. No significant difphenomenon was observed in a study with 1% and 2.7% amino acid-based solutions in uremic patients [5] . ferences were noted in the hydrolysis rates (K H or K* H ) An unexpected finding was that, in the case of four supply amino acids with a moderate increase in plasma amino acid concentration. amino acids (histidine, lysine, threonine and serine), the absolute amount of amino acid transported from dialy- based solution was about three times higher than that E-mail: jonas.bergstrom@kfcmail.hs.sll.se observed during the dwells with the amino acid-based solution, although the plasma concentration of these amino acids was similar during the dwells with the weak APPENDIX I dipeptide-based solution and during those with the amino Kinetic model for dipeptides and its constituent amino acids acid-based solution (Fig. 5) . Moreover, for all amino Following instillation of the dipeptide-based dialysis solution in the acids except phenylalanine, the increase in plasma conperitoneal cavity in rats, measurements of dipeptide and amino acid concentrations were performed in dialysate and blood. Since dipeptides centration at 60 minutes in relation to the dose delivered were not detected in blood it could be assumed that they were rapidly between 0 and 60 minutes was considerably higher durhydrolyzed in blood (or deposited in tissues) and their concentration ing the dwells with the amino acid-based solution than in blood was therefore assumed to be zero.
A with an amino acid-based solution.
The mass balance equation for dipeptides is therefore as follows:
The reason for this difference between amino acid and dipeptide-based solutions is not clear. A possible
explanation may be that amino acids, in the form of dipeptides, delivered to the splanchnic area from dialysis where C DD is the dipeptide concentration in dialysate. The fluid absorption rate (Q A ) is estimated by the RISA elimination coefficient (K E ).
fluid are taken up in the liver more efficiently (with less V D and K E were evaluated as described in the Calculation section.
delivery to the peripheral circulation) than the corre- the blood vessel walls (or peritoneal tissue) and slowly Amino acids are transported between the dialysate and plasma by hydrolyzed [20] . diffusion and the diffusive flow for each amino acid can be described as a product of the diffusive mass transport coefficient K BDA and the Conceivably, some of the adverse effects of amino concentration difference between plasma and dialysate for this amino acids, such as loss of appetite, nausea and vomiting, are acid. The convective flow of a particular amino acid from plasma to related to the concentrations of amino acids in blood, dialysate can be expressed as a product of the ultrafiltration flow rate, Q U , amino acid sieving coefficient, S A , and the average amino acid which may have effects mediated in the splanchnic area concentration, C A , calculated as an arithmetic mean of blood, C BA , and or in centers regulating appetite and satiety in the central dialysate, C DA , amino acid concentrations, C A ϭ (C BA ϩ C DA )/2. The nervous system [21, 22] . If this is the case, dipeptideconvective flow of amino acids from the peritoneal cavity can be described as a product of the fluid absorption rate, Q A , and C DA ; no based PD solutions should be advantageous because they sieving of amino acid in the convective flow from peritoneal cavity permit delivery of larger amounts of amino acids with was assumed (S A ϭ 1). The mass balance equation for each amino acid fewer side effects than do amino acid-based solutions.
produced in the peritoneal cavity by dipeptide hydrolysis is therefore as follows:
In summary (1) intraperitoneal dialysate volume decreases more slowly between 90 and 240 minutes during
a dwell with dipeptide-based solutions than with amino acid-based solutions;
(2) dipeptides are hydrolyzed in (Eq. 2) the peritoneal cavity, but at a much lower rate than the Note that each mass balance equation for a particular dipeptide (Eq. 1) rate of diffusive transport from the peritoneal cavity;
is accompanied by two mass balance equations for constituent amino acids (Eq. 2) with an identical amino acid generation rate, K H C DD .
(3) diffusive mass transport coefficients for amino acids (K BDA ) and for dipeptides (K BDD ) show a clear dependence on their molecular weights; (4) hydrolysis rate APPENDIX II coefficients for dipeptides in the peritoneal cavity differ Estimation of kinetic parameters between various dipeptides, which may be due to differ-Integration and rearrangement of equation 1 yields: ent affinities of particular dipeptides to the hydrolysis Y 1 (t n ) ϭ (K H ϩ K BDD )X 1 (t n ) (Eq. 3) enzyme; and (5) dipeptide-based solutions may be a better way, as compared to amino acid-based solutions, to where
